Scope of the Study
Tissue banks are bio repositories used for storing umbilical cord tissues and blood, also contain different types of stem cells, each with the potential to treat various injuries and diseases. The method of storing these samples are known as Tissue banking. The use of automated tissue banking is playing a vital role in blood fractionation, DNA extraction, labelling, and capping techniques. Tissue banking is involved in for treating various debilitating conditions such as neurological diseases, cardiovascular, cancer, diabetes mellitus and other autoimmune diseases. These banks help in the storage of various types of tissue samples such as skin, bone, cornea, heart valves, umbilical cord, and human soft tissues. Further, regenerative medicines getting more recognition in healthcare centers & the emerging demand for tissue banking in bone marrow transplant are few factors driving the tissue banking market.
The market study is being classified by Type (Heart valves, Cornea, Bone, Skin and Brain & Spinal cord), by Application (Therapeutics, Cosmetics, Research & development, Drug discovery and Others) and major geographies with country level break-up. According to AMA, the Global Tissue Banking market is expected to see growth rate of 7.49%
BioCision, LLC (United States), Thermo Fisher, Inc. (United States), Tecan Trading AG (Switzerland), BioKryo GmbH (Germany), Brooks Automation (United States), Chernobyl Tissue Bank (United Kingdom), Cureline (United States), Eppendorf (India), IMA Pharma (India) and LifeLink Tissue Bank (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Tata Memorial Hospital Tissue Bank (India), The PXE International Blood and Tissue Bank (United States), Tissue Banks International (United States), TuBaFrost Group (United States), Wisconsin Tissue Bank (United States) and Teva Pharmaceutical Industries Ltd. (Israel).
The Global Tissue Banking market is highly fragmented with the presence of several vendors. The global vendors are dominating the market, however, most of the product offerings of these companies are almost similar. To increase product sales, players are differentiating their products through automation, value-added services, and collaborations and partnerships with research and academic institutions. The companies are offering cost-effective consumables and are likely to succeed as tissue banks are concentrating on reducing the overall preservation cost of tissue banking
AdvanceMarketAnalytics has segmented the market of Global Tissue Banking market by Type, Application and Region.
On the basis of geography, the market of Tissue Banking has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Equipment, the sub-segment i.e. Cryopreservation Equipment will boost the Tissue Banking market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Tissue Type, the sub-segment i.e. Skin will boost the Tissue Banking market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Geriatric Population & Biobanks
- High Prevalence of Chronic Diseases and Need For Umbilical Cord Preservation
- Increasing Awareness for Tissue Donation
- Growing Adoption of Advanced Cosmetic Surgeries
- Surge in Government Initiatives to Promote Better Healthcare Facilities
- Technological advancements such as Ultra-low freezer and Automated Freezer having storage Capacity of 1 billion Samples
- Stringent Regulatory Requirements May Hamper the Market Growth
- Automation in Tissue banking
- Increasing R &D Investment in Healthcare Sector
- Limited standardization in sample collection & Number of Tissue Donors
Market Leaders and their expansionary development strategies
January 2018, C Vijaya Baskar (Health Minister of India) launched the first tissue bank at the Government Kilpauk Medical College Hospital in the Southern region, thereby powering the development of tissue banking market.
In July 2018, PHC Corporation introduced the new -85°C ultra-low temperature freezer VIP ECO series 1 using natural refrigerants 2 and new inverter compressors for the market in Japan, designed specifically for pharmaceutical companies and research and medical institutions. and This product series comprises of models that are specially designed for pharmaceutical companies, research, and medical institutions.
Key Target AudienceTissue Banking Storage Manufacturers, Government & Regulatory Bodies, Industry Associations, Potential Investors, Downstream Vendors and Biobanking Regulators
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase